Xolair and Cataract - a phase IV clinical study of FDA data
Summary:
Cataract is reported as a side effect among people who take Xolair (omalizumab), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Ventolin, and have High blood pressure.
The phase IV clinical study analyzes which people have Cataract when taking Xolair. It is created by eHealthMe based on reports of 77,224 people who have side effects when taking Xolair from the FDA, and is updated regularly.
What is Xolair?
Xolair has active ingredients of omalizumab. It is often used in asthma. eHealthMe is studying from 77,555 Xolair users. Check the latest studies of Xolair.
What is Cataract?
Cataract (clouding of the lens inside the eye) is found to be associated with 1,893 drugs and 2,132 conditions by eHealthMe. Check the latest studies of Cataract.
77,224 people reported to have side effects when taking Xolair.
Among them, 506 people (0.66%) have Cataract.
Among these 506 people:
How long have people been on Xolair when they have Cataract? *
What is the gender of people who have Cataract when taking Xolair? *
What is the age of people who have Cataract when taking Xolair? *
What are other drugs people take besides Xolair? *
What are other side effects people have besides Cataract? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Xolair and have Cataract?
- Check whether Cataract is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Xolair:
- Xolair (77,555 reports)
Cataract treatments and more:
- Cataract (70,565 reports)
How severe was Cataract and when was it recovered:
Expand to all the drugs that have ingredients of omalizumab:
- Cataract and drugs with ingredients of omalizumab (589 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Xolair:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cataract:
- Cataract (1,893 drugs)
Browse all the conditions that are associated with Cataract:
- Cataract (2,132 conditions)
Related publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on omalizumab (the active ingredients of Xolair) and Xolair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Appetite Decreased and drugs of ingredients of fulvestrant - now
- Appetite - Decreased and drugs of ingredients of fulvestrant - now
- Anal Ulcer and drugs of ingredients of ibuprofen - 13 seconds ago
- Could Ifosfamide cause Cardiac Disorder? - 14 seconds ago
- Cosentyx and Tamsulosin drug interactions for men aged 50-59 - 25 seconds ago
- Drug interactions of Potassium and Glucosamine - 26 seconds ago
- Victoza and Water Retention for Women aged 50-59 - 41 seconds ago
- Victoza and Fluid Retention for Women aged 50-59 - 41 seconds ago
- Avelox and Cardiac Failure for Women aged 40-49 - 42 seconds ago
- Toradol and Imitrex drug interactions for women aged 30-39 - 48 seconds ago